Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $484.3K | conv 35Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $994.8K | conv 37Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $519.4K | conv 45Cluster | SEC | |
NGM BIOPHARMACEUTICALS INCListing unverified | Buy | $165.5K | conv 28Cluster | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $123.7K | conv 33Cluster | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $6.5K | conv 25Cluster | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $189.3K | conv 25Cluster | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $4.2K | conv 33Cluster | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $440.1K | conv 61ClusterFirst in 12mo | SEC | |
RAPT Therapeutics, Inc.Listing unverified | Buy | $12.9M | conv 61ClusterFirst in 12mo | SEC |